Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort

• Published in: ESMO open Vol. 8; no. 3; p. 101559
• Main Authors: Mair, M.J., Mitterer, M., Buratti, T., Berchtold, L., Fong, D., Preusser, M.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.06.2023; The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology
• Subjects: Breakthrough Infections; cancer; Cohort Studies; COVID-19; COVID-19 - epidemiology; COVID-19 - prevention & control; Humans; Original Research; pandemic; SARS-CoV-2; Vaccination; COVID-19; SARS-CoV-2; cancer; pandemic; vaccination

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has particularly impacted patients with hemato-oncological malignancies, as they showed not only a higher propensity for severe courses but also weaker immune responses after vaccination. Still, data on the influence of pandem...